Login / Signup
Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance.
Emanuel Raschi
Michele Fusaroli
Igor Diemberger
Elisabetta Poluzzi
Published in:
Drug safety (2021)
Keyphrases
</>
direct oral anticoagulants
interstitial lung disease
systemic sclerosis
venous thromboembolism
atrial fibrillation
adverse drug
rheumatoid arthritis
idiopathic pulmonary fibrosis
drug induced
emergency department